Edge Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$218K Sell
923
-561
-38% -$130K 0.02% 300
2018
Q1
$324K Sell
1,484
-881
-37% -$207K 0.03% 257
2017
Q4
$530K Buy
2,365
+145
+7% +$30.9K 0.05% 209
2017
Q3
$419K Sell
2,220
-602
-21% -$115K 0.05% 229
2017
Q2
$529K Sell
2,822
-125
-4% -$22.5K 0.06% 208
2017
Q1
$486K Sell
2,947
-1,449
-33% -$230K 0.06% 225
2016
Q4
$630K Buy
+4,396
New +$589K 0.08% 191

Other funds holding ELV

Edge Advisors's ELV Position: Q2 2018 in Review

Edge Advisors reduced its Elevance Health (ELV) stake by 38% in Q2 2018, selling an estimated $130K and leaving 923 shares worth $218K. The position accounts for 0.02% of the portfolio, ranked #300.

Edge Advisors first reported a position in ELV in Q4 2016 and has held it in 7 quarters since. The position peaked at $630K in Q4 2016. 934 funds tracked by Wall St. Rank hold ELV as of Q2 2018.

  • Edge Advisors held 923 shares of Elevance Health worth $218K as of Q2 2018.
  • Edge Advisors sold 561 Elevance Health shares in Q2 2018, an estimated $130K.
  • Elevance Health made up 0.02% of Edge Advisors's portfolio in Q2 2018, its #300 holding.
  • Edge Advisors first reported a position in Elevance Health in Q4 2016 and has held it in 7 quarters since.
  • Edge Advisors's Elevance Health position peaked at $630K in Q4 2016.
  • 934 funds tracked by Wall St. Rank held Elevance Health as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.